H.O.P.E: Helping Ovarian Cancer Patients Cope

NCT02090582CompletedNAINTERVENTIONAL

Summary

The purpose of this study is to test the effect of the gynecologic oncologists with palliative care specialist collaboration (GO-PC) intervention on patient quality of life.

Key Facts

Lead Sponsor

Duke University

Enrollment

47

Start Date

2014-04-01

Completion Date

2020-04-30

Study Type

INTERVENTIONAL

Official Title

Pilot Study on H.O.P.E: Helping Ovarian Cancer Patients Cope During Disease Recurrence

Interventions

Structured Palliative CareUsual Care

Conditions

Platinum-resistant Ovarian CancerRecurrent Ovarian CancerPalliative Care

Eligibility

Age Range

18 Years+

Sex

FEMALE

Inclusion Criteria:

* Platinum-resistant ovarian cancer or recurrent ovarian cancer
* Ability to read and respond to questions in English

Exclusion Criteria:

* Platinum-sensitive recurrent ovarian cancer without a significant clinical event
* Existence of co-morbid disease, which in the opinion of the investigator prohibits participation in the protocol

Outcome Measures

Primary Outcomes

Quality of Life (Functional Assessment of Cancer Therapy for Ovarian Cancer and Functional Assessment of Chronic Illness Therapy for Palliative Care)

A combined FACT-O and FACIT-PAL (version 4)16 will be administered at baseline and 12 week intervals on all subjects. The FACT Measurement System is a validated group of questions that measure health-related QOL in cancer patients. Both questionnaires have identical questions for physical well-being, functional well-being, emotional well-being, and social well-being. The additional subscales of the FACT-O and FACIT-PAL will be combined to provide a comprehensive quality of life assessment specific to ovarian cancer and palliative care.

Time frame: Every 12 weeks for a maximum of 5 years

Locations

University of North Carolina, Chapel Hill, United States

Duke University Medical Center, Durham, United States

H.O.P.E: Helping Ovarian Cancer Patients Cope